Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Transformation to AML · Adult patients with myelodysplastic syndromes and thrombocytopenia

It is very uncertain whether thrombopoietin mimetics changes transformation to AML compared with placebo (very low certainty).

1 finding from 1 review

Thrombopoietin mimetics for patients with myelodysplastic syndromes 2017 · Cochrane Headline outcomes only
RR 1.02 [0.59, 1.77]
5 studies · 372 participants
Very low